Cargando…
Comparison of intranasal and intramuscular naloxone in opioid overdoses managed by ambulance staff: a double‐dummy, randomised, controlled trial
AIMS: To measure and evaluate clinical response to nasal naloxone in opioid overdoses in the pre‐hospital environment. DESIGN: Randomised, controlled, double‐dummy, blinded, non‐inferiority trial, and conducted at two centres. SETTING: Participants were included by ambulance staff in Oslo and Trondh...
Autores principales: | Skulberg, Arne Kristian, Tylleskär, Ida, Valberg, Morten, Braarud, Anne‐Cathrine, Dale, Jostein, Heyerdahl, Fridtjof, Skålhegg, Tore, Barstein, Jan, Mellesmo, Sindre, Dale, Ola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302677/ https://www.ncbi.nlm.nih.gov/pubmed/35137493 http://dx.doi.org/10.1111/add.15806 |
Ejemplares similares
-
NTNU intranasal naloxone trial (NINA-1) study protocol for a double-blind, double-dummy, non-inferiority randomised controlled trial comparing intranasal 1.4 mg to intramuscular 0.8 mg naloxone for prehospital use
por: Skulberg, Arne Kristian, et al.
Publicado: (2020) -
Prehospital naloxone administration – what influences choice of dose and route of administration?
por: Tylleskar, Ida, et al.
Publicado: (2020) -
The pharmacokinetic interaction between nasally administered naloxone and the opioid remifentanil in human volunteers
por: Tylleskar, Ida, et al.
Publicado: (2021) -
Inhaled nitric oxide as temporary respiratory stabilization in patients with COVID-19 related respiratory failure (INOCOV): Study protocol for a randomized controlled trial
por: Hagemo, Jostein Skjalg, et al.
Publicado: (2022) -
Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial
por: Dietze, Paul, et al.
Publicado: (2019)